CLINICAL_TRIALS
trial_result
· 2015-04-08
Clinical Trial Update: Tear Cytokine Analysis as a Prediction or Diagnostic Marker in Ocular GvHD
Summary
The trial evaluated tear cytokines as a potential predictor or diagnostic marker for ocular graft-versus-host disease, and the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Yonsei University | Conditions: Chronic Graft-versus-host Disease | Status: COMPLETED